Gary Steinberg
Overview
Explore the profile of Gary Steinberg including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
48
Citations
1147
Followers
0
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Annapureddy D, Taylor J, Kamat A, ODonnell M, Howard J, Tan W, et al.
Eur Urol Focus
. 2025 Feb;
PMID: 39922753
Background And Objective: Current data on bacillus Calmette-Guérin (BCG)-unresponsive non-muscle-invasive bladder cancer (NMIBC) do not differentiate outcomes by clinical stage. The purpose of this study is to investigate the role...
2.
Taylor J, Kamat A, Annapureddy D, Khene Z, Howard J, Tan W, et al.
Eur Urol Oncol
. 2024 Dec;
PMID: 39694798
Background And Objective: Non-muscle-invasive bladder cancer (NMIBC) patients treated with additional bacillus Calmette-Guérin (BCG) may become unresponsive to BCG. Recently, sequential intravesical gemcitabine and docetaxel (gem/doce) are being used for...
3.
Taylor J, Kamat A, ODonnell M, Annapureddy D, Howard J, Tan W, et al.
BJU Int
. 2024 Aug;
135(2):260-268.
PMID: 39183466
Objective: To quantify the oncological risks of bladder-sparing therapy (BST) in patients with Bacillus Calmette-Guérin (BCG)-unresponsive non-muscle-invasive bladder cancer (NMIBC) compared to upfront radical cystectomy (RC). Patients And Methods: Pre-specified...
4.
Li R, Hensley P, Gupta S, Al-Ahmadie H, Babjuk M, Black P, et al.
Eur Urol
. 2024 Aug;
86(6):516-527.
PMID: 39183090
Background And Objective: There has been a recent surge in the development of agents for bacillus Calmette-Guérin-unresponsive (BCG-U) non-muscle-invasive bladder cancer (NMIBC). Critical assessment of these agents and practical recommendations...
5.
Hussein R, Shin D, Zhao M, Guo J, Davidzon G, Steinberg G, et al.
Med Image Anal
. 2024 Jan;
93:103072.
PMID: 38176356
Accurate quantification of cerebral blood flow (CBF) is essential for the diagnosis and assessment of a wide range of neurological diseases. Positron emission tomography (PET) with radiolabeled water (O-water) is...
6.
Salimi-Jazia F, Wood L, Jones R, Chandler J, Rafeeqi T, Dutta S, et al.
J Pediatr Surg
. 2023 Jul;
58(11):2268.
PMID: 37500373
No abstract available.
7.
Pohar K, Patel S, Lotan Y, Trabulsi E, Woods M, Downs T, et al.
Urol Oncol
. 2022 Jun;
40(8):382.e1-382.e6.
PMID: 35750559
Purpose: The therapeutic benefit of intravesical instillation of hexaminolevulinate (HAL) at the time of transurethral resection of bladder tumor (TURBT) has been demonstrated in multiple studies. The purpose of this...
8.
Tan W, Steinberg G, Witjes J, Li R, Shariat S, Roupret M, et al.
Eur Urol Oncol
. 2022 Jun;
5(5):505-516.
PMID: 35718695
Context: Intermediate-risk (IR) non-muscle-invasive bladder cancer (NMIBC) is a heterogeneous disease. Objective: To update the International Bladder Cancer Group (IBCG) guidance and provide practical recommendations on IR NMIBC management. Evidence...
9.
Salimi-Jazi F, Wood L, Jones R, Chandler J, Rafeeqi T, Dutta S, et al.
J Pediatr Surg
. 2022 Feb;
57(11):710-715.
PMID: 35197196
Background: The omental flap has numerous extraperitoneal applications in reconstruction and revascularization given its favorable immunologic and angiogenic properties. In patients with Moyamoya disease, cerebral revascularization using a pedicled omental...
10.
Roumiguie M, Kamat A, Bivalacqua T, Lerner S, Kassouf W, Bohle A, et al.
Eur Urol
. 2021 Dec;
82(1):34-46.
PMID: 34955291
Context: A large proportion of patients with non-muscle-invasive bladder cancer (NMIBC) fall in the gap between bacillus Calmette-Guérin (BCG)-naïve and BCG-unresponsive disease. As multiple therapeutic agents move into this gray...